Table 2. Correlations of CALR and PDIA3 expressions with clinicopathological parameters of patients with NSCLC.
CALR | PDIA3 | ||||||
---|---|---|---|---|---|---|---|
Parameters | n | Low | High | P | Low | High | P |
(n = 25) | (n = 63) | (n = 33) | (n = 55) | ||||
Gender | |||||||
Male | 46 | 12 | 34 | 0.613 | 20 | 26 | 0.225 |
Female | 42 | 13 | 29 | 13 | 29 | ||
Age (years) | |||||||
≥ 62 | 44 | 13 | 31 | 0.813 | 14 | 30 | 0.271 |
< 62 | 44 | 12 | 32 | 19 | 25 | ||
Tumor sizes (cm) | |||||||
≤ 3 | 33 | 7 | 26 | 0.246 | 10 | 23 | 0.280 |
> 3 | 55 | 18 | 37 | 23 | 32 | ||
Lymph node metastases | |||||||
0 | 37 | 13 | 24 | 0.233 | 12 | 25 | 0.403 |
≥ 1 | 51 | 12 | 39 | 21 | 30 | ||
AJCC stages | |||||||
I | 27 | 8 | 19 | 0.866 | 8 | 19 | 0.310 |
II + III | 61 | 17 | 44 | 25 | 36 | ||
Pathological grades | |||||||
I + I–II + II | 62 | 19 | 43 | 0.473 | 25 | 37 | 0.398 |
II–III + III | 26 | 6 | 20 | 8 | 18 |
Cases of group “–” and “+” were assigned to group low. Cases of group “++” and “+++” were assigned to group high.